Tissue-Engineered Lungs for in Vivo Implantation

Waiting to Exhale Lung tissue does not regenerate, so, when it is damaged by disease and/or surgically removed, lung transplantation is often the only treatment option. Because donor tissue is in short supply, there has been a long-standing interest in engineering functional and transplantable lung tissue in the laboratory. Petersen et al. (p. 538, published online 24 June; see the Perspective by Wagner and Griffith) now report an important step in this direction. After gently removing the cellular constituents of rat lungs with detergent, the residual scaffold of extracellular matrix—which retained the compliance and mechanical properties of the original lung—was re-seeded with a mixture of lung epithelial and endothelial cells and cultured in a bioreactor. Within a few days, the engineered lung tissue contained alveoli, microvessels, and small airways that were repopulated with the appropriate cell types. When transplanted into a rat for short time periods, the engineered lung showed evidence of gas exchange. Decellularized rat lungs rebuilt with new cells in vitro can function at a rudimentary level when implanted back into a rat. Because adult lung tissue has limited regeneration capacity, lung transplantation is the primary therapy for severely damaged lungs. To explore whether lung tissue can be regenerated in vitro, we treated lungs from adult rats using a procedure that removes cellular components but leaves behind a scaffold of extracellular matrix that retains the hierarchical branching structures of airways and vasculature. We then used a bioreactor to culture pulmonary epithelium and vascular endothelium on the acellular lung matrix. The seeded epithelium displayed remarkable hierarchical organization within the matrix, and the seeded endothelial cells efficiently repopulated the vascular compartment. In vitro, the mechanical characteristics of the engineered lungs were similar to those of native lung tissue, and when implanted into rats in vivo for short time intervals (45 to 120 minutes) the engineered lungs participated in gas exchange. Although representing only an initial step toward the ultimate goal of generating fully functional lungs in vitro, these results suggest that repopulation of lung matrix is a viable strategy for lung regeneration.

[1]  D. Defouw Ultrastructural features of alveolar epithelial transport. , 1983, The American review of respiratory disease.

[2]  N. Teich,et al.  Postnatal development of alveoli. Regulation and evidence for a critical period in rats. , 1985, The Journal of clinical investigation.

[3]  C. Fujiyama,et al.  Reconstruction of alveolus-like structure from alveolar type II epithelial cells in three-dimensional collagen gel matrix culture. , 1993, The American journal of pathology.

[4]  L. Abdullah,et al.  Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. , 1996, American journal of respiratory cell and molecular biology.

[5]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[6]  M. Inanlou,et al.  The role of fetal breathing-like movements in lung organogenesis. , 2005, Histology and histopathology.

[7]  Charles A Vacanti,et al.  Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. , 2006, Tissue engineering.

[8]  Mengyan Li,et al.  Engineering three-dimensional pulmonary tissue constructs. , 2006, Tissue engineering.

[9]  A R Boccaccini,et al.  Biocompatibility of Poly-DL-lactic acid (PDLLA) for Lung Tissue Engineering , 2006, Journal of biomaterials applications.

[10]  Stephen F Badylak,et al.  Decellularization of tissues and organs. , 2006, Biomaterials.

[11]  S. Keshavjee,et al.  Cell-based tissue engineering for lung regeneration. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[12]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[13]  C. Ehrhardt,et al.  In vitro cell culture models for the assessment of pulmonary drug disposition , 2008 .

[14]  Sara Mantero,et al.  Clinical transplantation of a tissue-engineered airway , 2008, The Lancet.

[15]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[16]  A. Bishop,et al.  Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. , 2008, Proceedings of the American Thoracic Society.

[17]  J. Orens,et al.  General overview of lung transplantation and review of organ allocation. , 2009, Proceedings of the American Thoracic Society.

[18]  D. M. Simons,et al.  Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application. , 2009, Tissue engineering. Part A.

[19]  Anthony Atala,et al.  Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[20]  D. Calame,et al.  Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.